A prospective, real-world, observational cohort study of pyrotinib in HER2-positive metastatic breast cancer (MBC) patients
Latest Information Update: 25 Nov 2021
At a glance
- Drugs Pyrotinib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 25 Nov 2021 New trial record